Michael Fayon
Overview
Explore the profile of Michael Fayon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fayon M, Beaufils F
Pediatr Pulmonol
. 2024 Oct;
PMID: 39453791
Simple clinical indices, complex composite phenotyping/endotyping and telehome monitoring now allow us to evaluate the risk of preschool wheezing on a population or individual level. We herein discuss the usefulness...
2.
Beaufils F, Delhaes L, Esteves P, Michelet M, Bebear C, Begueret H, et al.
Pediatr Allergy Immunol
. 2024 Oct;
35(10):e14253.
PMID: 39365292
No abstract available.
3.
Beaufils F, Mondenx M, Fayon M, Menard J, Begueret H, Michelet M, et al.
Am J Respir Crit Care Med
. 2024 Jul;
210(7):941-944.
PMID: 39012258
No abstract available.
4.
Fletcher C, Hadchouel A, Thumerelle C, Mazenq J, Fleury M, Corvol H, et al.
Thorax
. 2024 Jul;
79(9):842-852.
PMID: 38964860
Introduction: Interstitial lung disease in children (chILD) are rare and mostly severe lung diseases. Very few epidemiological data are available in limited series of patients. The aim of this study...
5.
Neehus A, Carey B, Landekic M, Panikulam P, Deutsch G, Ogishi M, et al.
Cell
. 2024 May;
187(13):3460.
PMID: 38776920
No abstract available.
6.
Lejeune S, Bouazza N, Nicaise P, Jolaine V, Roditis L, Marguet C, et al.
Pediatr Allergy Immunol
. 2024 Mar;
35(3):e14112.
PMID: 38520021
Background: It is unclear whether sensitization patterns differentiate children with severe recurrent wheeze (SRW)/severe asthma (SA) from those with non-severe recurrent wheeze (NSRW)/non-severe asthma (NSA). Our objective was to determine...
7.
Neehus A, Carey B, Landekic M, Panikulam P, Deutsch G, Ogishi M, et al.
Cell
. 2023 Dec;
187(2):390-408.e23.
PMID: 38157855
We describe a human lung disease caused by autosomal recessive, complete deficiency of the monocyte chemokine receptor C-C motif chemokine receptor 2 (CCR2). Nine children from five independent kindreds have...
8.
Beaufils F, Esteves P, Enaud R, Prevel R, Henrot P, Campagnac M, et al.
J Allergy Clin Immunol Pract
. 2023 Dec;
12(4):1067-1070.
PMID: 38128699
No abstract available.
9.
Bouteleux B, Beaufils F, Fayon M, Bui S
Pediatr Pulmonol
. 2023 Nov;
59(3):552-561.
PMID: 38014613
Background: Pulmonary exacerbations (PEx) are strong predictors of respiratory disease progression in children with cystic fibrosis (CwCF) and may be associated with persistent decreased lung function after acute management. Telemonitoring...
10.
Lussac-Sorton F, Charpentier E, Imbert S, Lefranc M, Bui S, Fayon M, et al.
Front Cell Infect Microbiol
. 2023 Oct;
13:1271117.
PMID: 37780857
The advent of CFTR modulators represents a turning point in the history of cystic fibrosis (CF) management, changing profoundly the disease's clinical course by improving mucosal hydration. Assessing changes in...